These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 38433837)

  • 1. Update on current and new potential immunotherapies in breast cancer, from bench to bedside.
    Alaluf E; Shalamov MM; Sonnenblick A
    Front Immunol; 2024; 15():1287824. PubMed ID: 38433837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy in HER2-positive breast cancer: state of the art and future perspectives.
    Krasniqi E; Barchiesi G; Pizzuti L; Mazzotta M; Venuti A; Maugeri-Saccà M; Sanguineti G; Massimiani G; Sergi D; Carpano S; Marchetti P; Tomao S; Gamucci T; De Maria R; Tomao F; Natoli C; Tinari N; Ciliberto G; Barba M; Vici P
    J Hematol Oncol; 2019 Oct; 12(1):111. PubMed ID: 31665051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancing Immunotherapy in Metastatic Breast Cancer.
    Mansour M; Teo ZL; Luen SJ; Loi S
    Curr Treat Options Oncol; 2017 Jun; 18(6):35. PubMed ID: 28534250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thermal immuno-nanomedicine in cancer.
    Yang Z; Gao D; Zhao J; Yang G; Guo M; Wang Y; Ren X; Kim JS; Jin L; Tian Z; Zhang X
    Nat Rev Clin Oncol; 2023 Feb; 20(2):116-134. PubMed ID: 36604531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast Cancer Immunology and Immunotherapy: Current Status and Future Perspectives.
    de la Cruz-Merino L; Chiesa M; Caballero R; Rojo F; Palazón N; Carrasco FH; Sánchez-Margalet V
    Int Rev Cell Mol Biol; 2017; 331():1-53. PubMed ID: 28325210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging immunotherapeutic strategies for the treatment of breast cancer.
    Huppert LA; Mariotti V; Chien AJ; Soliman HH
    Breast Cancer Res Treat; 2022 Jan; 191(2):243-255. PubMed ID: 34716870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy for Breast Cancer Treatment: Current Evidence and Therapeutic Options.
    Singh K; Yadav D; Jain M; Singh PK; Jin JO
    Endocr Metab Immune Disord Drug Targets; 2022; 22(2):212-224. PubMed ID: 33902424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Cancer Moonshot Immuno-Oncology Translational Network at 5: accelerating cancer immunotherapies.
    Annapragada A; Sikora AG; Marathe H; Liu S; Demetriou M; Fong L; Gao J; Kufe D; Morris ZS; Vilar E; Sharon E; Hutson A; Odunsi K
    J Natl Cancer Inst; 2023 Nov; 115(11):1262-1270. PubMed ID: 37572314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remodeled tumor immune microenvironment (TIME) parade via natural killer cells reprogramming in breast cancer.
    Elanany MM; Mostafa D; Hamdy NM
    Life Sci; 2023 Oct; 330():121997. PubMed ID: 37536617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy for Breast Cancer is Finally at the Doorstep: Immunotherapy in Breast Cancer.
    De La Cruz LM; Czerniecki BJ
    Ann Surg Oncol; 2018 Oct; 25(10):2852-2857. PubMed ID: 30014455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of radiation and immunotherapy in breast cancer - Treatment implications.
    Ye JC; Formenti SC
    Breast; 2018 Apr; 38():66-74. PubMed ID: 29253718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer vaccines as a targeted immunotherapy approach for breast cancer: an update of clinical evidence.
    Abbaspour M; Akbari V
    Expert Rev Vaccines; 2022 Mar; 21(3):337-353. PubMed ID: 34932427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer genomics and immuno-oncological markers to guide immune therapies.
    Hammerl D; Smid M; Timmermans AM; Sleijfer S; Martens JWM; Debets R
    Semin Cancer Biol; 2018 Oct; 52(Pt 2):178-188. PubMed ID: 29104025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current State of Cell Therapies for Breast Cancer.
    Gautam N; Elleson KM; Ramamoorthi G; Czerniecki BJ
    Cancer J; 2022 Jul-Aug 01; 28(4):301-309. PubMed ID: 35880940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy for triple-negative breast cancer: Existing challenges and exciting prospects.
    Jia H; Truica CI; Wang B; Wang Y; Ren X; Harvey HA; Song J; Yang JM
    Drug Resist Updat; 2017 May; 32():1-15. PubMed ID: 29145974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Immune Landscape of Breast Cancer: Strategies for Overcoming Immunotherapy Resistance.
    Retecki K; Seweryn M; Graczyk-Jarzynka A; Bajor M
    Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tecemotide: an antigen-specific cancer immunotherapy.
    Wurz GT; Kao CJ; Wolf M; DeGregorio MW
    Hum Vaccin Immunother; 2014; 10(11):3383-93. PubMed ID: 25483673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour-infiltrating lymphocytes and the emerging role of immunotherapy in breast cancer.
    Luen SJ; Savas P; Fox SB; Salgado R; Loi S
    Pathology; 2017 Feb; 49(2):141-155. PubMed ID: 28049579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
    Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M
    J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy strategies in the treatment of breast cancer.
    Soliman H
    Cancer Control; 2013 Jan; 20(1):17-21. PubMed ID: 23302903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.